Skip to content
Search

Latest Stories

India’s Insurance Industry to Climb £216.38 Billion By FY 2020: Report

India’s insurance industry is expected to grow to £216.38 billion by fiscal year (FY) 2020 with the government’s flagship Ayushman Bharat – the National Health Protection Mission (AB-NHPM) and other growth drivers such as rise in disposable income, presence of global players and easing of the regulatory regime supporting the penetration of the insurance culture in the country, said The Associated Chambers of Commerce and Industry of India (ASSOCHAM) and research firm APAS.

The medium-term outlook for the life insurance industry remains robust, with solid premium growth forecast over the next five years to 2023, the report said.


Overall insurance penetration in the country reached 3.7 per cent in 2017 from 2.71 per cent in 2001. Gross premium increased from £37.85 bn in the FY 2012 to reach close to 55.61 bn in FY 2018.

It said, Ayushman Bharat , the ambitious scheme of the Indian government covering 100 million poor and vulnerable families with a cover of £5342 per family of tertiary care and hospitalisation, would be a game changer for the country’s insurance industry,  as it would have a great multiplier impact on a host of allied sectors and create thousands of new jobs.

The private sector companies which presently hold close to 48 per cent market share in the general insurance and 29 per cent in the life insurance would see a big growth in the opportunities. The private sector hospitals would also be major partners in the rollout of the countrywide scheme for which an initial sum of £1.28 bn has been provided.

Taking stock of the present state of play, the ASSOCHAM study with the research firm APAS said that the domestic life insurance industry registered 11 per cent year-on-year growth for new business premium in FY 2017-18 generating revenue of £23.17 bn. The premiums for non-life insurance industry increased by 17.5 per cent year-on-year.

Meanwhile, the government has taken a number of initiatives to boost the insurance industry. The Foreign Direct Investment (FDI) limit has been increased from 26 per cent to 49 per cent , while the regulator, Insurance Regulatory and Development Authority (IRDA), has allowed insurers investments up to 10 per cent in additional tier 1 (AT1) bonds that are issued by banks to increase their tier 1 capital.

More For You

Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less
India-US trade talks collapse over tariff disputes

FILE PHOTO: US president Donald Trump and Indian prime minister Narendra Modi shake hands as they attend a joint press conference at the White House in Washington, D.C., U.S., February 13, 2025. REUTERS/Kevin Lamarque.

India-US trade talks collapse over tariff disputes

TRADE talks between India and the US have hit a roadblock over disagreements on import duties for auto components, steel and farm goods, Indian officials with direct knowledge said, dashing hopes of reaching a deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

The deadlock marks a sharp shift from earlier optimism, following Trump's claim that New Delhi had proposed a "no tariffs" agreement for American goods, and officials from both sides suggesting India could be among the first countries to strike a deal on the new US tariffs.

Keep ReadingShow less